Stocks with high levels of insider buying the past 3 months and good analyst coverage.

Analysts Target

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
388	HK$371.00	-3.9%	-10.6%	HK$477.3b	HK$518.47	24.9	5.0%	3.5%	Diversified Financials
2020	HK$67.55	-7.8%	-27.6%	HK$194.4b	HK$104.84	12.0	8.3%	3.6%	Consumer Durables
175	HK$17.82	-9.0%	4.8%	HK$188.2b	HK$29.30	10.8	16.8%	2.8%	Automobiles
1929	HK$11.83	-7.1%	-8.7%	HK$120.5b	HK$15.67	13.0	9.5%	5.7%	Retail
823 New	HK$35.42	-3.8%	-17.4%	HK$92.4b	HK$45.11	0.6	51.3%	7.2%	Real Estate
1177	HK$4.42	-5.8%	-15.5%	HK$79.3b	HK$8.70	29.1	16.9%	2.3%	Pharmaceuticals & Biotech
1093	HK$6.84	-3.4%	-14.3%	HK$78.3b	HK$11.57	20.7	14.8%	4.2%	Pharmaceuticals & Biotech
6181	HK$404.00	-14.0%	-53.0%	HK$76.8b	HK$931.69	12.7	19.3%	6.8%	Consumer Durables
9926 New	HK$85.50	1.0%	-12.4%	HK$76.4b	HK$172.16	22.3	61.0%	n/a	Pharmaceuticals & Biotech
6862	HK$11.31	-6.8%	-24.3%	HK$63.5b	HK$17.70	13.5	9.5%	6.4%	Consumer Services
2313	HK$40.46	-6.6%	-23.8%	HK$61.2b	HK$65.83	9.0	7.3%	6.7%	Consumer Durables
1364	HK$20.38	-5.6%	-18.8%	HK$48.6b	HK$34.32	13.5	14.5%	2.4%	Consumer Services
151	HK$4.00	-2.7%	-23.8%	HK$47.1b	HK$5.63	9.7	3.7%	4.0%	Food, Beverage & Tobacco
960	HK$6.34	-17.4%	-32.3%	HK$46.8b	HK$10.30	38.1	33.8%	0%	Real Estate Management and Development
1530	HK$16.43	-0.3%	-27.5%	HK$40.2b	HK$36.33	4.2	-38.7%	1.5%	Pharmaceuticals & Biotech
3939	HK$8.31	-20.6%	11.2%	HK$39.2b	HK$16.66	23.5	46.6%	2.0%	Materials
1828	HK$29.02	-5.0%	n/a	HK$38.3b	HK$44.75	28.5	28.4%	n/a	Insurance
101 New	HK$7.24	-5.9%	4.3%	HK$36.5b	HK$10.82	20.3	17.3%	7.2%	Real Estate Management and Development
23	HK$13.07	-3.0%	8.2%	HK$34.3b	HK$14.41	0.3	23.6%	4.7%	Banks
425	HK$28.02	-9.8%	32.5%	HK$33.4b	HK$49.34	10.5	13.2%	2.7%	Automobiles
1877	HK$16.25	-1.6%	-29.3%	HK$30.9b	HK$29.91	5.3	69.1%	n/a	Pharmaceuticals & Biotech
1318	HK$52.45	-8.7%	-51.6%	HK$26.7b	HK$106.18	18.5	21.3%	2.2%	Household
1044	HK$21.82	-10.4%	-1.7%	HK$26.4b	HK$28.51	8.6	3.3%	7.4%	Household
2096	HK$9.36	-5.8%	-17.2%	HK$23.8b	HK$17.87	15.5	18.0%	2.2%	Pharmaceuticals & Biotech

High Insider Buying